The emergence of bacteria with antibiotic resistance and multiple resistance is characteristic of animal and human pathogens. It is wide known that bee products, which have been used in alternative medicine since ancient times, have antimicrobial potential. Application of bee products for therapeutic purposes is defined as apitherapy. The study aimed to evaluate the antimicrobial activity of commercial chestnut honey, pollen and propolis produced in western Bosnia and Herzegovina (Sanski Most) individually and in five combinations (apimixtures). The antimicrobial properties of samples were investigated using the agar well diffusion method against three Gram-positive bacteria (Bacillus subtilis subsp. spizizenii ATCC 6633, Methicillin-resistant Staphylococcus aureus ATCC 33591, Enterococcus faecalis ATCC 29212); three Gram-negative bacteria (ESBL producing Escherichia coli ATCC 35218, Salmonella enterica subsp. enterica serovar Enteritidis ATCC 13076, Pseudomonas aeruginosa ATCC 9027) and one fungal species (Candida albicans ATCC 10231). Pure bee pollen inhibited the growth of only Gram-negative bacteria, concentrated chestnut honey was active against all Gram-negative and Gram-positivebacteria, while 20% propolis extract and apimixtures A2 (80% honey and 20% propolis) and A3 (60% honey, 20% pollen and 20% propolis extract) inhibited the growth of all tested microorganisms. Chestnut honey andthree apimixtures (A1, A2 and A3) showed the highest antibacterial action against all tested Gram-negative bacteria and MRSA compared to other investigated samples. In this study, examined honeybee products from Bosnia and Herzegovina and their mixtures had significant activity against tested bacteria, including strains with proven resistance to conventional antibiotics, MRSA and ESBL producing E. coli.

Aims: The aim of this study was to conduct antimicrobial analysis on novel Schiff base-derived cobalt(II) complexes (Co(L1) 2 and Co(L2) 2 )

Amaranthaceae Juss. family encompasses many edible plants with prominent biological activity. This investigation tested the bioactive properties of ethanolic and methanolic extract of three well-known species: spinach (Spinacia oleracea L.), chard (Beta vulgaris L. subsp. vulgaris), and orache (Atriplex hortensis L.) through the determination of total phenolic and flavonoid content, antioxidant activity, and antibacterial properties. The particular goal was to evaluate the antibiofilm potential of extracts and to demarcate concentration-depending changes in the biofilm-forming category of included bacterial strains. The mass of the chard and orache methanolic extracts gained by maceration are lower in comparison to the mass of ethanolic extracts obtained by the Soxhlet method. In the case of spinach, the results are the opposite. All extracts have an antiradical activity that can be attributed to the established amounts of phenols and flavonoids. Total phenolics in dry leaves ranged from 0.09 to 0.44 mg GAE/g dw, and total flavonoids from 0.42 to 1.9 mg RTE/g dw. All investigated extracts performed inhibitory potential in terms of bacterial growth, while there was no bactericidal effect observed. Values of the minimum inhibitory concentration ranged from 125 µg/ml to 500 µg/ml. Overall results suggested orache extracts as the strongest inhibitory agents. Antibiofilm assays showed that examined extracts of spinach, chard, and orache caused changes in the biofilm-forming capacity of investigated bacterial pathogens. Fluctuations in observed biofilm-forming categories after application of extracts were concentration-dependent.

Sweet cherry (Prunus avium L.) stems in the form of infusions and decoctions are traditionally consumed for diuretic and anti-inflammatory purposes. This study aimed to evaluate antimicrobial and antibiofilm activity of ethanolic and methanolic extract made from sweet cherry stems. Extracts are obtained by the Soxhlet extraction and maceration procedures. For the determination of the minimum inhibitory concentration, the broth microdilution method is employed, and the assessment of the microbiocidal activity of the extracts is conducted. The antibiofilm activity was tested through the tissue culture plate method, which also allowed the determination of the biofilm-forming categories of investigated strains. The final step involved the calculation of the biofilm inhibition percentage. Examined extracts with the balanced activity inhibited the growth of all microorganisms, with Gram-negative bacteria being more sensitive in comparison to Gram-positive. The values of the minimum inhibitory concentration were 125 µg/ml, and 250 µg/ml, respectfully. Candida albicans was the most susceptible and the minimum inhibitory concentration of both extracts was 62.50 µg/ml. The microbiocidal activity of the extracts was not recorded. Extracts exhibited different impacts on the biofilm-forming capacity of the investigated microbes, and both inhibition and stimulation effects are noted. The percentage of the biofilm inhibition was from 14.27% to 84.78%, with the highest inhibition recorded for the multidrug-resistant Escherichia coli, treated with the ethanolic extract. Sweet cherry stems are a valuable source of natural bioactive compounds, but their usage in the treatment of microbial infections should be correctly and carefully implemented.